rofecoxib has been researched along with Colitis, Ulcerative in 6 studies
Colitis, Ulcerative: Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rofecoxib appears to control arthralgia in almost two-thirds of inflammatory bowel disease patients." | 5.11 | Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial. ( Biancone, L; Emerenziani, S; Fina, D; Geremia, A; Pallone, F; Petruzziello, C; Tosti, C, 2004) |
| "Patients with Crohn's disease, ulcerative colitis, or pouchitis who used celecoxib or rofecoxib were identified from computerized prescription records." | 3.71 | Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease. ( Loftus, EV; Mahadevan, U; Sandborn, WJ; Tremaine, WJ, 2002) |
| " While these drugs effectively reduce musculoskeletal pain and stiffness, long-term use is limited by gastrointestinal (GI) adverse effects (AEs) and disease exacerbation." | 2.50 | Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease. ( Hu, RW; Li, HY; Li, JS; Miao, XP; Ouyang, Q; Zhang, Y, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miao, XP | 1 |
| Li, JS | 1 |
| Ouyang, Q | 1 |
| Hu, RW | 1 |
| Zhang, Y | 1 |
| Li, HY | 1 |
| Charachon, A | 1 |
| Petit, T | 1 |
| Lamarque, D | 1 |
| Soulé, JC | 1 |
| Biancone, L | 1 |
| Tosti, C | 1 |
| Geremia, A | 1 |
| Fina, D | 1 |
| Petruzziello, C | 1 |
| Emerenziani, S | 1 |
| Pallone, F | 1 |
| Wilcox, GM | 1 |
| Mattia, AR | 1 |
| Goh, J | 1 |
| Wight, D | 1 |
| Parkes, M | 1 |
| Middleton, SJ | 1 |
| Hunter, JO | 1 |
| Mahadevan, U | 1 |
| Loftus, EV | 1 |
| Tremaine, WJ | 1 |
| Sandborn, WJ | 1 |
1 review available for rofecoxib and Colitis, Ulcerative
| Article | Year |
|---|---|
Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Colitis, Ulcerative; Crohn Disease; Cyclooxygena | 2014 |
1 trial available for rofecoxib and Colitis, Ulcerative
| Article | Year |
|---|---|
Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Colitis, Ulcerative; Crohn Disease | 2004 |
4 other studies available for rofecoxib and Colitis, Ulcerative
| Article | Year |
|---|---|
[Acute ulcerative colitis in a patient treated with rofecoxib who took aspirin as self-medication].
Topics: Abdominal Pain; Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Biopsy; | 2003 |
Rofecoxib and inflammatory bowel disease: clinical and pathologic observations.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Biopsy; Colitis, Ulcerative; Colon | 2005 |
Rofecoxib and cytomegalovirus in acute flare-up of ulcerative colitis: coprecipitants or coincidence?
Topics: Aged; Colitis, Ulcerative; Cyclooxygenase Inhibitors; Cytomegalovirus Infections; Humans; Lactones; | 2002 |
Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease.
Topics: Adult; Aged; Celecoxib; Colitis, Ulcerative; Crohn Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhib | 2002 |